HomeCompareCBLEQ vs PFE

CBLEQ vs PFE: Dividend Comparison 2026

CBLEQ yields 723.17% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CBLEQ wins by $1190199.83M in total portfolio value
10 years
CBLEQ
CBLEQ
● Live price
723.17%
Share price
$1.60
Annual div
$11.57
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1190199.88M
Annual income
$935,679,320,699.94
Full CBLEQ calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — CBLEQ vs PFE

📍 CBLEQ pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCBLEQPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CBLEQ + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CBLEQ pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CBLEQ
Annual income on $10K today (after 15% tax)
$61,469.67/yr
After 10yr DRIP, annual income (after tax)
$795,327,422,594.95/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, CBLEQ beats the other by $795,327,400,275.05/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CBLEQ + PFE for your $10,000?

CBLEQ: 50%PFE: 50%
100% PFE50/50100% CBLEQ
Portfolio after 10yr
$595099.96M
Annual income
$467,839,673,479.33/yr
Blended yield
78.62%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

CBLEQ
Analyst Ratings
1
Hold
3
Sell
Consensus: Sell
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CBLEQ buys
0
PFE buys
0
No recent congressional trades found for CBLEQ or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCBLEQPFE
Forward yield723.17%6.13%
Annual dividend / share$11.57$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$1190199.88M$49.6K
Annual income after 10y$935,679,320,699.94$26,258.71
Total dividends collected$1169714.58M$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusSellHold

Year-by-year: CBLEQ vs PFE ($10,000, DRIP)

YearCBLEQ PortfolioCBLEQ Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$83,017$72,317.26$9,153$693.39+$73.9KCBLEQ
2$649,911$561,082.26$8,593$849.25+$641.3KCBLEQ
3$4,800,546$4,105,141.10$8,336$1,066.78+$4.79MCBLEQ
4$33,475,367$28,338,783.58$8,437$1,384.80+$33.47MCBLEQ
5$220,503,880$184,685,237.09$9,013$1,875.40+$220.49MCBLEQ
6$1,372,883,712$1,136,944,560.12$10,306$2,680.72+$1372.87MCBLEQ
7$8,084,643,279$6,615,657,707.69$12,820$4,101.38+$8084.63MCBLEQ
8$45,060,206,127$36,409,637,817.54$17,673$6,826.70+$45060.19MCBLEQ
9$237,869,680,933$189,655,260,377.37$27,543$12,591.86+$237869.65MCBLEQ
10$1,190,199,879,298$935,679,320,699.94$49,560$26,258.71+$1190199.83MCBLEQ

CBLEQ vs PFE: Complete Analysis 2026

CBLEQStock

Headquartered in Chattanooga, TN, CBL Properties owns and manages a national portfolio of market-dominant properties located in dynamic and growing communities. CBL's portfolio is comprised of 107 properties totaling 66.7 million square feet across 26 states, including 65 high quality enclosed, outlet and open-air retail centers and 8 properties managed for third parties. CBL seeks to continuously strengthen its company and portfolio through active management, aggressive leasing and profitable reinvestment in its properties. On November 1, 2020, CBL & Associates Properties, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of Texas.

Full CBLEQ Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this CBLEQ vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CBLEQ vs SCHDCBLEQ vs JEPICBLEQ vs OCBLEQ vs KOCBLEQ vs MAINCBLEQ vs JNJCBLEQ vs MRKCBLEQ vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.